HYBRID NUCLEIC ACID SWITCHES Read more about HYBRID NUCLEIC ACID SWITCHES US Application 17/602,204Filed on 2021-10-07
Anti-Human Papillomavirus 16 E6 T Cell Receptors Read more about Anti-Human Papillomavirus 16 E6 T Cell Receptors Japan2021-166407Filed on 2021-10-08
Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome Read more about Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome Patent Cooperation TreatyPCT/US2021/057229Filed on 2021-10-29
Chimeric Antigen Receptors Targeting B-cell Maturation Antigen Read more about Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US Application 17/745,067Filed on 2022-05-16
STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION Sweden18720845.9Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION Poland18720845.9Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION The Netherlands18720845.9Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION Italy18720845.9Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION United Kingdom18720845.9Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION France18720845.9Filed on 2018-04-05